Tendon regeneration in human and equine athletes:Ubi Sumus-Quo Vadimus (Where are We and Where are We Going to)?

Sports Medicine

Volumn 42, Issue 10, 2012, Pages 871-890

  Spaas, Jan H ^a   Guest, Deborah J ^b   Van De Walle, Gerlinde R ^a  

^a GHENT UNIVERSITY   (Belgium)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Growth factors; platelets; sports injuries; sports medicine; tendon injuries; wound healing

Indexed keywords

ANIMAL; ANIMAL DISEASE; ATHLETE; ELASTICITY; FEMALE; HORSE; HUMAN; INJURY; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; TENDON; TENDON INJURY; TISSUE REGENERATION; TREATMENT OUTCOME;

ANIMALS; ATHLETES; ELASTICITY; FEMALE; GUIDED TISSUE REGENERATION; HORSES; HUMANS; MALE; STEM CELL TRANSPLANTATION; TENDON INJURIES; TENDONS; TREATMENT OUTCOME;

EID: 84866116452     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.2165/11635390-000000000-00000     Document Type: Review

References (192)

1. Nirchls RP. Patterns of failed hearing in tendon injury. In: Leadbetter WB, Buckwalter JA, Gordon SL, editors. Sports-induced inflammation: clinical and basic science concepts. Park Ridge (IL): American Academy of Orthopaedic Surgeons, 1990: 577
2. Riley G. The pathogenesis of tendinopathy:a molecular perspective. Rheumatology (Oxford) 2004 Feb; 43 (2): 131-42
3. Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports 1997 Apr; 7 (2): 107-12 (Pubitemid 127521858)
4. Pinchbeck GL, Clegg PD, Proudman CJ, et al. Horse injuries and racing practices in national hunt racehorses in the UK: the results of a prospective cohort study. Vet J 2004 Jan; 167 (1): 45-52 (Pubitemid 37554941)
5. Kasashima Y, Takahashi T, Smith RKW, et al. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese thoroughbred flat racehorses in 1999. Equine Vet J 2004 May; 36 (4): 346-50 (Pubitemid 38703367)
6. Singer ER, Barnes J, Saxby F, et al. Injuries in the event horse: training versus competition. Vet J 2008 Jan; 175 (1): 76-81 (Pubitemid 351187519)
7. van den Belt AJ, Dik KJ, Barneveld A. Ultrasonographic evaluation and long-term follow-up of flexor tendonitis/desmitis in the metacarpal/metatarsal region in Dutch warmblood horses and standardbred racehorses. Vet Q 1994 May; 16 Suppl. 2: 76-80
8. Ippolito E, Postacchini F, Ricciardi-Pollini PT. Biochemical changes in the matrix of human tendons in relation to age and pathological conditions. Ital J Orthop Traumatol 1975; 1: 133-9
9. Perkins NR, Reid SW, Morris RS. Risk factors for injury to the superficial digital flexor tendon and suspensory apparatus in thoroughbred racehorses in New Zealand. N Z Vet J 2005 Jun; 53 (3): 184-92 (Pubitemid 40814361)
10. Stege JP, Stubbe JH, Verhagen EA, et al. Risk factors for injuries in male professional soccer: a systematic review. Brit J Sport Med 2011 Apr; 45 (4): 375-6
11. Fuller CW, Dick RW, Corlette J, et al. Comparison of the incidence, nature and cause of injuries sustained on grass and new generation artificial turf by male and female football players. Part 2: training injuries. Brit J Sport Med 2007 Aug; 41 Suppl. 1: i27-32
12. Fuller CW, Dick RW, Corlette J, et al. Comparison of the incidence, nature and cause of injuries sustained on grass and new generation artificial turf by male and female football players. Part 1: match injuries. Brit J Sport Med 2007 Aug; 41 Suppl. 1: i20-6
13. Young LJ, Medina D, DeOme KB, et al. The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol 1971 Feb 1; 6 (1): 49-56
14. Thorpe CT, Clegg PD, Birch HL. A review of tendon injury: why is the equine superficial digital flexor tendon most at risk? Equine Vet J 2010 Mar; 42 (2): 174-80
15. Ohberg L, Lorentzon R, Alfredson H. Eccentric training in patients with chronic Achilles tendinosis: normalised tendon structure and decreased thickness at follow up. Brit J Sport Med 2004 Feb 1; 38 (1): 8-11 (Pubitemid 38183592)
16. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Brit J Sport Med 2009 Jun; 43 (6): 409-16
17. Dowling BA, Dart AJ, Hodgson DR, et al. Superficial digital flexor tendonitis in the horse. Equine Vet J 2000 Sep; 32 (5): 369-78
18. Richardson LE, Dudhia J, Clegg PD, et al. Stem cells in veterinary medicine: attempts at regenerating equine tendon after injury. Trends Biotechnol 2007 Sep; 25 (9): 409-16 (Pubitemid 350147117)
19. Waselau M, Sutter WW, Genovese RL, et al. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in standardbred racehorses. J Am Vet Med Assoc 2008 May 15; 232 (10): 1515-20 (Pubitemid 351703455)
20. Jozsa LG, Kannus P, editors. Overuse injuries of tendons. Human tendons: anatomy, physiology and pathology. Champaign (IL): Human Kinetics, 1997; 164-253
21. Stromberg B, Wiederhielm CA. Viscoelastic description of a collagenous tissue in simple elongation. J Appl Physiol 1969; 26: 857-62
22. Riemersma DJ, Schamhardt HC. In vitro mechanical properties of equine tendons in relation to cross-sectional area and collagen content. Res Vet Sci 1985 Nov; 39 (3): 263-70
23. Crevier N, Pourcelot P, Denoix JM, et al. Segmental variations of in vitro mechanical properties in equine superficial digital flexor tendons. Am J Vet Res 1996 Aug; 57 (8): 1111-7 (Pubitemid 126496537)
24. Kader D, Saxena A, Movin T, et al. Achilles tendinopathy: some aspects of basic science and clinical management. Brit J Sport Med 2002 Aug; 36 (4): 239-49 (Pubitemid 34833115)
25. Stephens PR, Nunamaker DM, Butterweck DM. Application of a hall-effect transducer for measurement of tendon strains in horses. Am J Vet Res 1989 Jul; 50 (7): 1089-95
26. Ketchum LD. Tendon healing, fundamentals of wound management in surgery. New York (NY): Appleton-Century-Crofts, 1979
27. Kajikawa Y, Morihara T, Watanabe N, et al. GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. J Cell Physiol. 2007 Mar; 210 (3): 684-91 (Pubitemid 46185038)
28. Manske PR, Gelberman RH, Vande Berg JS, et al. Intrinsic flexor tendon repair: a morphologic study in vitro. J Bone Joint Surg 1984; 66: 385-96 (Pubitemid 14169459)
29. Birch HL, Bailey AJ, Goodship AE. Macroscopic 'degeneration' of equine superficial flexor tendon is accompanied by a change in extracellular matrix composition. Equine Vet J 1998; 30: 534-9 (Pubitemid 128527090)
30. McCullagh KG, Goodship AE, Silver IA. Tendon injuries and their treatment in the horse. Vet Rec 1979; 105 (3): 54-7
31. Williams IF, Heaton A, McCullagh KG. Cell morphology and collagen types in equine tendon scar. Res Vet Sci 1980; 28: 302-10 (Pubitemid 10042917)
32. Obaid H, Connell D. Cell therapy in tendon disorders: what is the current evidence? Am J Sports Med 2010 Oct; 38 (10): 2123-32
33. Rudolph R, Woodward M, Hurn I. Ultrastructure of active versus passive contracture of wounds. Surg Gynecol Obstet 1980; 151: 396-400 (Pubitemid 10053960)
34. Smith RKW, Davis CS. Diagnosis and management of tendon and ligament disorders. 3rd ed. Equine Surgery 2006; 1089: 98-107
35. Gillis CL. Rehabilitation of tendon and ligament injuries. Proc Am Assoc Eq Pract 1997; 43: 306
36. Bowring B, Chockalingam N. Conservative treatment of tibialis posterior tendon dysfunction: a review. Foot 2010 Mar; 20 (1): 18-26
37. Maffulli N, Longo UG, Loppini M, et al. Current treatment options for tendinopathy. Expert Opin Pharma-cother 2010 Sep; 11 (13): 2177-86
38. Peers KH, Lysens RJ. Patellar tendinopathy in athletes: current diagnostic and therapeutic recommendations. Sports Med 2005; 35 (1): 71-87 (Pubitemid 40170626)
39. Mafi N, Lorentzon R, Alfredson H. Superior short-term results with eccentric calf muscle training compared to concentric training in a randomized prospective multicenter study on patients with chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc 2001; 9 (1): 42-7 (Pubitemid 33684587)
40. Henninger R. Treatment of superficial digital flexor tendinitis. Vet Clin N Am: Eq Pract 1994; 10: 409-24
41. Speed CA. Fortnightly review: corticosteroid injections in tendon lesions. BMJ 2001 Aug 18; 323 (7309): 382-6 (Pubitemid 32762466)
42. Yamada T, Gotoh M, Nakama K, et al. Effects of hyaluronan on cell proliferation and mRNA expression of pro-collagens alpha 1 (I) and alpha 1 (III) in tendon-derived fibroblasts from patients with rotator cuff disease: an in vitro study. Am J Sports Med 2007 Nov; 35 (11): 1870-6 (Pubitemid 350029352)
43. Foland JW, Trotter GW, Powers BE, et al. Effect of sodium hyaluronate in collagenase-induced superficial digital flexor tendinitis in horses. Am J Vet Res 1992; 53: 2371-6 (Pubitemid 23020340)
44. Moraes JR, Facco GG, Moraes FR, et al. Effects of glycosaminoglycan polysulphate on the organisation of collagen fibres in experimentally induced tendonitis in horses. Vet Rec 2009 Aug 15; 165 (7): 203-5
45. Marr CM, Love S, Boyd JS, et al. Factors affecting the clinical outcome of injuries to the superficial digital flexor tendon in national hunt and point-to-point racehorses. Vet Rec 1993 May 8; 132 (19): 476-9
46. Reef VB, Genovese RL, Davis WM. initial long term results in horses with superficial digital flexor tendinitis treated with intralesional beta-aminoproprionitril fuma-rate. Proc Am Assoc Eq Pract 1997; 43: 301-5
47. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004 Jul; 36 (5): 415-9 (Pubitemid 38891289)
48. Nessler JP, Mass DP. Direct-current electrical stimulation of tendon healing in vitro. Clin Orthop Relat Res 1987 Apr; (217): 303-12 (Pubitemid 17066427)
49. Norrie RD. A preliminary report on regenerative healing in the equine tendon. Am J Vet Res 1975 Oct; 36 (10): 1523-4
50. Watkins JP, Auer JA, Morgan SJ, et al. Healing of surgically created defects in the equine superficial digital flexor tendon: effects of pulsing electromagnetic field therapy on collagen-type transformation and tissue morphologic reorganization. Am J Vet Res 1985 Oct; 46 (10): 2097-103
51. Kaneps AJ, Hultgren BD, Riebold TW, et al. Laser therapy in the horse: histopathologic response. Am J Vet Res 1984; 45 (3): 581-2
52. Marr CM, Love S, Boyd JS, et al. Factors affecting the clinical outcome of injuries to the superficial digital flexor tendon in National Hunt and point-to-point racehorses. Vet Rec 1993; 132: 476-9
53. Stasinopoulos D, Stasinopoulos I, Pantelis M, et al. Comparing the effects of exercise program and low-level laser therapy with exercise program and polarized polychromatic non-coherent light (bioptron light) on the treatment of lateral elbow tendinopathy. Photomed Laser Surg 2009 Jun; 27 (3): 513-20
54. Stergioulas A, Stergioula M, Aarskog R, et al. Effects of low-level laser therapy and eccentric exercises in the treatment of recreational athletes with chronic achilles tendinopathy. Am J Sport Med 2008 May; 36 (5): 881-7 (Pubitemid 351551243)
55. Zwerver J, Dekker F, Pepping GJ. Patient guided piezoelectric extracorporeal shockwave therapy as treatment for chronic severe patellar tendinopathy: a pilot study. J Back Musculoskelet 2010; 23 (3): 111-5
56. Crowe OM, Dyson SJ, Wright IM, et al. Treatment of chronic or recurrent proximal suspensory desmitis using radial pressure wave therapy in the horse. Equine Vet J 2004 May; 36 (4): 313-6 (Pubitemid 38703361)
57. Waquespack RW, Burba DJ, Hubert JD, et al. Effects of extracorporeal shock wave therapy on desmitis of the accessory ligament of the deep digital flexor tendon in the horse. Vet Surg 2011 Jun; 40 (4): 450-6
58. Kersh KD, McClure SR, Van Sickle D, et al. The evaluation of extracorporeal shock wave therapy on collagenase induced superficial digital flexor tendonitis. Vet Comp Orthop Traumatol 2006; 19 (2): 99-105 (Pubitemid 43944327)
59. Bosch G, de Mos M, van Binsbergen R, et al. The effect of focused extracorporeal shock wave therapy on collagen matrix and gene expression in normal tendons and ligaments. Equine Vet J 2009 Apr; 41 (4): 335-41
60. Henninger RW, Bramlage LR, Bailey M, et al. Effects of tendon splitting on experimentally-induced acute equine tendinitis. Vet Comp Orthop Traumatol 1992; 5: 1-9
61. Tnibar MA. Medial patellar ligament splitting for the treatment of upward fixation of the patella in 7 equids. Vet Surg 2002 Sep-Oct; 31 (5): 462-7
62. Southwood LL, Stashak TS, Kainer RA, et al. Desmotomy of the accessory ligament of the superficial digital flexor tendon in the horse with use of a tenoscopic approach to the carpal sheath. Vet Surg 1999 Mar-Apr; 28 (2): 99-105 (Pubitemid 129742400)
63. Nixon AJ. Endoscopy of the digital flexor tendon sheath in horses. Vet Surg 1990; 19 (4): 266-71
64. Magee AA, Ragle CA, Howlett MR. Use of tenoscopy for management of septic tenosynovitis caused by a penetrating porcupine quill in the synovial sheath surrounding the digital flexor tendons of a horse. J Am Vet Med Assoc 1997; 210 (12): 1768-70 (Pubitemid 127471202)
65. Todhunter PG, Schumacher J, Finn-Bodner ST. Desmotomy for treatment of chronic desmitis of the accessory ligament of the deep digital flexor tendon in a horse. Can Vet J 1997 Oct; 38 (10): 637-9 (Pubitemid 127510860)
66. de Vos RJ, Weir A, Tol JL, et al. No effects of PRP on ultrasonographic tendon structure and neovascularisa-tion in chronic midportion Achilles tendinopathy. Brit J Sport Med 2011 Apr; 45 (5): 387-92
67. Bosch G, Moleman M, Barneveld A, et al. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports 2011 Aug; 21 (4): 554-61
68. Bosch G, van Schie HT, de Groot MW, et al. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res 2010 Feb; 28 (2): 211-7
69. Arguelles D, Carmona JU, Climent F, et al. Autologous platelet concentrates as a treatment for musculoskeletal lesions in five horses. Vet Rec 2008 Feb 16; 162 (7): 208-11 (Pubitemid 351421112)
70. Torricelli P, Fini M, Filardo G, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011; 35 (10): 1569-76
71. Favata M, Beredjiklian PK, Zgonis MH, et al. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J Orthop Res 2006 Nov; 24 (11): 2124-32 (Pubitemid 44717975)
72. Guest DJ, Smith MR, Allen WR. Equine embryonic stemlike cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 2010 Oct; 42 (7): 636-42
73. Chen X, Zou XH, Yin GL, et al. Tendon tissue engineering with mesenchymal stem cells and biografts: an option for large tendon defects? Front Biosci (Schol Ed) 2009; 1: 23-32
74. Awad HA, Boivin GP, Dressler MR, et al. Repair of patellar tendon injuries using a cell-collagen composite. J Orthop Res. 2003 May; 21(3): 420-31 (Pubitemid 36546808)
75. Schnabel LV, Lynch ME, van der Meulen MC, et al. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum super-ficialis tendons. J Orthop Res 2009 Oct; 27 (10): 1392-8
76. Lacitignola L, Crovace A, Rossi G, et al. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun. 2008 Sep; 32 Suppl 1: S33-8
77. Herthel DJ. Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components. Proc Am Assoc Eq Pract 2001; 47: 319-21
78. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008; 30 (20-22): 1752-8
79. Godwin EE, Young NJ, Dudhia J, et al. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012 Jan; 44 (1) 25-32
80. Nixon AJ, Dahlgren LA, Haupt JL, et al. Effect of adiposederived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008 Jul; 69 (7): 928-37
81. Del Bue M, Ricco S, Ramoni R, et al. Equine adiposetissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun 2008 Sep; 32 Suppl. 1: S51-5
82. Ju YJ, Muneta T, Yoshimura H, et al. Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Cell Tissue Res 2008 Jun; 332 (3): 469-78
83. Spaas JH, Gambacurta A, Polettini M, et al. Purification and expansion of stem cells from equine peripheral blood, with clinical applications. Vlaams Dierg Tijdschrift 2011; 80 (2): 129-35
84. Cao Y, Liu Y, Liu W, et al. Bridging tendon defects using autologous tenocyte engineered tendon in a hen model. Plast Reconstr Surg 2002 Oct; 110 (5): 1280-9
85. Chen J, Qian Y, Wu B, et al. Autologous tenocyte therapy for experimental achilles tendinopathy in a rabbit model. Tissue Eng (Part A) 2011 Apr 15; 17 (15-16): 2037-48
86. Casey PJ. A new generation of tenocytes grown in-vitro to effect tendon repair and regeneration [abstract]. Proceedings of the European Veterinary Conference, Voorjaarsdagen; 2011 Apr 27-29; Amsterdam, 287-8
87. Connell D, Datir A, Alyas F, et al. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Brit J Sport Med 2009 Apr; 43 (4): 293-8
88. Clarke AW, Alyas F, Morris T, et al. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med 2011 Mar; 39 (3): 614-23
89. Obaid H, Clarke A, Rosenfeld P, et al. Skin-derived fibroblasts for the treatment of refractory achilles tendinosis: preliminary short-term results. J Bone Joint Surg Am 2012 Feb 1; 94 (3): 193-200
90. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008 Dec; 1 (3-4): 165-74
91. Mishra A, Woodall Jr J, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sport Med 2009 Jan; 28 (1): 113-25
92. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Brit J Sport Med 2008 May; 42 (5): 314-20 (Pubitemid 351702675)
93. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant dentistry. 2001; 10 (4): 225-8
94. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003; 33 (5): 381-94 (Pubitemid 36560710)
95. de Mos M, van der Windt AE, Jahr H, et al. Can plateletrich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008 Jun; 36 (6): 1171-8 (Pubitemid 351713047)
96. de Vos RJ, van Veldhoven PL, Moen MH, et al. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull 2010; 95: 63-77
97. Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007 Feb; 25 (2): 230-40 (Pubitemid 46344249)
98. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature 2001 Nov 1; 414 (6859): 92-7
99. Paris DB, Stout TA. Equine embryos and embryonic stem cells: defining reliable markers of pluripotency. Ther-iogenology 2010 Sep 1; 74 (4): 516-24
100. Chan EM, Ratanasirintrawoot S, Park IH, et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009 Nov; 27 (11): 1033-7
101. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998 Nov 6; 282 (5391): 1145-7 (Pubitemid 28516247)
102. Li X, Zhou SG, Imreh MP, et al. Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells Dev 2006 Aug; 15 (4): 523-31 (Pubitemid 44701172)
103. De Vos J, Assou S, Tondeur S, et al. Human embryonic stem cells: from the human embryo transgressed to the regenerative medicine of tomorrow. Gynecol Obstet Fertil 2009 Jul-Aug; 37 (7-8): 620-6
104. Stojkovic M, Lako M, Stojkovic P, et al. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 2004; 22 (5): 790-7 (Pubitemid 39166936)
105. Kempf H, Lecina M, Ting S, et al. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells. Stem Cell Res 2011 Nov; 7 (3): 198-209
106. Lensch MW, Schlaeger TM, Zon LI, et al. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 2007 Sep 13; 1 (3): 253-8 (Pubitemid 47355327)
107. Marion RM, Blasco MA. Telomeres and telomerase in adult stem cells and pluripotent embryonic stem cells. Adv Exp Med Biol 2010; 695: 118-31
108. Chou YF, Yabuuchi A. Murine embryonic stem cell derivation, in vitro pluripotency characterization, and in vivo teratoma formation. Curr Protoc Toxicol 2011 Nov; Chapter 2: Unit 2 22 [online]. Available from URL: http://onlinelibrary.wiley.com/doi/10.1002/0471140856.tx0222s50/pdf [Accessed 2012 Aug 24]
109. Sanchez L, Gutierrez-Aranda I, Ligero G, et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 2010; 29 (2): 251-62
110. Chen X, Song XH, Yin Z, et al. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors. Stem Cells 2009 Jun; 27 (6): 1276-87
111. Guest DJ, Allen WR. Expression of cell-surface antigens and embryonic stem cell pluripotency genes in equine blastocysts. Stem Cells Dev 2007 Oct; 16 (5): 789-96
112. Watts AE, Yeager AE, Kopyov OV, et al. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Res Ther 2011 Jan 27; 2 (1): 4-16
113. Takahashi K, Okita K, Nakagawa M, et al. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2 (12): 3081-9
114. Zhao T, Zhang ZN, Rong Z, etal. Immunogenicity of induced pluripotent stem cells. Nature 2011 Jun 9; 474 (7350): 212-5
115. Hussein SM, Nagy K, Nagy A. Human induced pluripotent stem cells: the past, present, and future. Clin Pharm Ther 2011 May; 89 (5): 741-5
116. Nagy K, Sung HK, Zhang P, et al. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 2011; 7 (3): 693-702
117. Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem 2010 Nov 1; 111 (4): 769-81
118. De Schauwer C, Meyer E, Van de Walle GR, et al. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. Theriogenology 2011 May; 75 (8): 1431-43
119. Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther 2008 May; 8 (5): 569-81 (Pubitemid 351685023)
120. Fong EL, Chan CK, Goodman SB. Stem cell homing in musculoskeletal injury. Biomaterials 2011 Jan; 32 (2): 395-409
121. Shi Y, Hu G, Su J, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010 May; 20 (5): 510-8
122. Prockop DJ, Brenner M, Fibbe WE, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010 Sep; 12 (5): 576-8
123. Charbord P, Livne E, Gross G, et al. Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev 2011 Mar; 7 (1): 32-42
124. Kuo CK, Tuan RS. Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng (Part A) 2008 Oct; 14 (10): 1615-27
125. Lee CH, Shah B, Moioli EK, et al. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 2010 Sep 1; 120 (9): 3340-9
126. Hankemeier S, van Griensven M, Ezechieli M, et al. Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in im-munodeficient rats: results of a histologic study. Arch Orthop Trauma Surg 2007 Nov; 127 (9): 815-21 (Pubitemid 47566535)
127. Dyson SJ, Arthur RM, Palmer SE, et al. Suspensory ligament desmitis. Vet Clin N Am: Eq Pract 1995; 11: 177-215
128. Dyson SJ. Proximal suspensory desmitis in the forelimb and the hindlimb. Proc Am Assoc Eq Pract 2000; 46: 137-42
129. Dyson SJ. Medical management of superficial digital flexor tendinitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004; 36: 415-9 (Pubitemid 38891289)
130. Tapp H, Hanley EN, Patt JC, et al. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med (Maywood) 2009 Jan; 234 (1): 1-9
131. Little D, Guilak F, Ruch DS. Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells. Tissue Eng (Part A) 2010 Jul; 16 (7): 2307-19
132. Blasi A, Martino C, Balducci L, et al. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell 2011; 3 (1): 5
133. Kryger GS, Chong AKS, Costa M, et al. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering. J Hand Surg-Am 2007 May-Jun; 32A (5): 597-605 (Pubitemid 46680377)
134. Albano JJ, Alexander RW. Autologous fat grafting as a mesenchymal stem cell source and living bioscaffold in a patellar tendon tear. Clin J Sports Med 2011 Jul; 21 (4): 359-61
135. Kisiday JD, Kopesky PW, Evans CH, et al. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008 Mar; 26 (3): 322-31
136. Vidal MA, Robinson SO, Lopez MJ, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 2008 Dec; 37 (8): 713-24
137. Frisbie DD, Cross MW, McIlwraith CW. A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee. Vet Comp Orthop Traumatol 2006; 19 (3): 142-6 (Pubitemid 44378927)
138. De Bari C, Dell'Accio F, Vandenabeele F, et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003 Mar 17; 160 (6): 909-18 (Pubitemid 36350845)
139. Park SB, Seo MS, Kang JG, et al. Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy 2011 Mar; 13 (3): 341-9
140. Manuelpillai U, Moodley Y, Borlongan CV, et al. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 2011 May 11; 32 (S4): S320-5
141. Shaw SWS, David AL, De Coppi P. Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid. Curr Opin Obstet Gyn 2011 Apr; 23 (2): 109-16
142. De Schauwer C, Meyer E, Cornillie P, et al. Optimization of the isolation, culture, and characterization of equine umbilical cord blood mesenchymal stromal cells. Tissue Eng (Part C Methods) 2011 Nov; 17 (11): 1061-70
143. Hoynowski SM, Fry MM, Gardner BM, et al. Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun 2007 Oct 19; 362 (2): 347-53 (Pubitemid 47334921)
144. Koch TG, Heerkens T, Thomsen PD, et al. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007; 7: 26-35
145. Zeddou M, Briquet A, Relic B, et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 2010 Jul; 34 (7): 693-701
146. Reed SA, Johnson SE. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 2008 May; 215 (2): 329-36 (Pubitemid 351468944)
147. Carrade DD, Owens SD, Galuppo LD, et al. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses. Cytotherapy 2011 Apr; 13 (4): 419-30
148. Carrade DD, Affolter VK, Outerbridge CA, et al. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy 2011 Sep 7; 13 (10): 1180-92
149. Spaas JH, De Schauwer C, Cornillie P, et al. In vitro culture and characterization of equine peripheral blood mesen-chymal stromal cells. Vet J 2012; Under resubmission
150. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2 (6): 477-88 (Pubitemid 32223796)
151. Fenwick S, Harrall R, Hackney R, et al. Endochondral ossification in Achilles and patella tendinopathy. Rheumatology (Oxford) 2002 Apr; 41 (4): 474-6 (Pubitemid 34537854)
152. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007 Oct; 13 (10): 1219-27 (Pubitemid 47530625)
153. Chen JM, Willers C, Xu J, et al. Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits. Tissue Eng 2007 Jul; 13 (7): 1479-91 (Pubitemid 47105756)
154. Yao L, Bestwick CS, Bestwick LA, et al. Phenotypic drift in human tenocyte culture. Tissue Eng 2006 Jul; 12 (7): 1843-9 (Pubitemid 44162843)
155. Nixon AJ, Goodrich LR, Scimeca MS, et al. Gene therapy in musculoskeletal repair. Ann N Y Acad Sci 2007 Nov; 1117: 310-27 (Pubitemid 350191284)
156. Meyerrose T, Olson S, Pontow S, et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 2010 Sep 30; 62 (12): 1167-74
157. Wang XT, Liu PY, Tang JB. Tendon healing in vitro: genetic modification of tenocytes with exogenous PDGF gene and promotion of collagen gene expression. J Hand Surg-Am 2004 Sep; 29A (5): 884-90 (Pubitemid 39311586)
158. Hou Y, Mao Z, Wei X, et al. Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing. Matrix Biol 2009 Jul; 28 (6): 324-35
159. Dahlgren LA, van der Meulen MC, Bertram JE, et al. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res 2002 Sep; 20 (5): 910-9
160. Hoffmann A, Pelled G, Turgeman G, et al. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest 2006 Apr; 116 (4): 940-52
161. Gulotta LV, Kovacevic D, Packer JD, et al. Bone marrowderived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model. Am J Sport Med 2011 Jun; 39 (6): 1282-9
162. Menendez P, Bueno C, Wang L, et al. Human embryonic stem cells: potential tool for achieving immunotolerance? Stem Cell Rev 2005; 1 (2): 151-8 (Pubitemid 43074200)
163. Riordan NH, Ichim TE, Min WP, et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7: 29-36
164. Djouad F, Charbonnier LM, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007 Aug; 25 (8): 2025-32 (Pubitemid 47258180)
165. English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 2008 Jan 15; 115 (1): 50-8 (Pubitemid 350298590)
166. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 May 15; 99 (10): 3838-43 (Pubitemid 34534559)
167. Nasef A, Chapel A, Mazurier C, et al. Identification of IL10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 2007; 13 (4-5): 217-26 (Pubitemid 47024153)
168. Ortiz LA, DuTreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and an-tifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007 Jun 26; 104 (26): 11002-7 (Pubitemid 47175216)
169. Nemeth K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009 Jan; 15 (1): 42-9
170. Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006 Jan 1; 107 (1): 367-72 (Pubitemid 43053565)
171. Fang BJ, Song YP, Lin QD, et al. Human adipose tissuederived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 2007 Nov; 11 (7): 814-7
172. Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006 May 27; 81 (10): 1390-7 (Pubitemid 43847148)
173. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res 2005 Apr 15; 65 (8): 3035-9 (Pubitemid 40524580)
174. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007 Oct 1; 67 (19): 9142-9 (Pubitemid 47535900)
175. Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using auto-logous platelet lysate technique. Curr Stem Cell Res Ther 2011 Dec; 6 (4): 368-78
176. Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 2010 Mar; 5 (1): 81-93
177. Rauch C, Feifel E, Amann EM, et al. Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. Altex-Altern Anim Ex 2011; 28 (4): 305-16
178. Schallmoser K, Bartmann C, Rohde E, et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007 Aug; 47 (8): 1436-46 (Pubitemid 47101060)
179. Chen GK, Gulbranson DR, Hou ZG, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011 May; 8 (5): 424-U76
180. Crovace A, Lacitignola L, De Siena R, et al. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 2007 Aug; 31 Suppl 1: 281-3 (Pubitemid 47244324)
181. Harris MT, Butler DL, Boivin GP, et al. Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs. J Orthop Res 2004 Sep; 22 (5): 998-1003 (Pubitemid 39145116)
182. Bosch U, Krettek C. Tissue engineering of tendons and ligaments: a new challenge [in German]. Unfallchirurg 2002 Feb; 105 (2): 88-94 (Pubitemid 36062302)
183. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine-principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 2009 Feb; 50 (2): 155-65
184. Longo UG, Lamberti A, Maffulli N, et al. Tissue engineered biological augmentation for tendon healing: a systematic review. Br Med Bull 2011; 98: 31-59
185. Nixon AJ, Watts AE, Schnabel LV. Cell- and gene-based approaches to tendon regeneration. J Shoulder Elbow Surg 2012 Feb; 21 (2): 278-94
186. Fortier LA, Smith RK. Regenerative medicine for tendinous and ligamentous injuries of sport horses. Vet Clin North Am Equine Pract 2008 Apr; 24 (1): 191-201 (Pubitemid 351308103)
187. Borjesson DL, Peroni JF. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease. Clin Lab Med 2011 Mar; 31 (1): 109-23
188. Becerra J, Santos-Ruiz L, Andrades JA, et al. The stem cell niche should be a key issue for cell therapy in regenerative medicine. Stem Cell Rev 2011 Jun; 7 (2): 248-55
189. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumor-igenesis and metastasis. J Cell Physiol 2010 Feb; 222 (2): 268-77
190. Engler AJ, Sen S, Sweeney HL, et al. Matrix elasticity directs stem cell lineage specification. Cell 2006 Aug 25; 126 (4): 677-89 (Pubitemid 44233625)
191. Food and Drug Administration. Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Washington, DC: FDA, Division of Metabolism and Endocrine Drug Products, 1994 [online]. Available from URL: http://www.fda.gov/downloads/../ UCM131206.pdf [Accessed 2012 Aug 27]
192. Smith RK, Webbon PM. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Brit J Sport Med 2005 Sep; 39 (9): 582-4 (Pubitemid 41265299)